NASDAQ:BLU BELLUS Health (BLU) Stock Price, News & Analysis → Democrats’ “break glass for emergency” candidate for 2024 (From The Freeport Society) (Ad) Free BLU Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$14.74▼$14.7550-Day Range$14.42▼$14.7552-Week Range$6.38▼$14.76Volume3.45 million shsAverage Volume3.08 million shsMarket Capitalization$1.87 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get BELLUS Health alerts: Email Address Ad The Freeport SocietyDemocrats’ “break glass for emergency” candidate for 2024Nate Silver has been a celebrity pundit since at least the 2008 election, when he correctly predicted the winner in 49 of 50 states, and nailed all 35 Senate election outcomes. But interestingly, one man reached the same conclusion as Nate Silver a long time ago…For full details, click here. About BELLUS Health Stock (NASDAQ:BLU)BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.Read More Ad The Freeport SocietyDemocrats’ “break glass for emergency” candidate for 2024Nate Silver has been a celebrity pundit since at least the 2008 election, when he correctly predicted the winner in 49 of 50 states, and nailed all 35 Senate election outcomes. But interestingly, one man reached the same conclusion as Nate Silver a long time ago…For full details, click here. BLU Stock News HeadlinesMay 25, 2024 | yahoo.comHealth department warning of blue-green algae bloom in West Palm areaMay 19, 2024 | morningstar.comValbiotis SA ALVALApril 26, 2024 | markets.businessinsider.comBlueprint Medicines: Buy Rating Affirmed on BLU-808 Prospects and Strong Ayvakit Sales ForecastMarch 21, 2024 | msn.comDeal reached between Dignity Health, Arizona Blue Cross Blue ShieldMarch 4, 2024 | msn.comThe effects of 'blue light' on human health are still unclear, says panelJanuary 4, 2024 | msn.comGlowing blue waves off Orange County coast make for thrilling start to New YearDecember 21, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Bluebird Bio (BLUE), United Therapeutics (UTHR)September 21, 2023 | forbes.comCBD Dosage: How Much Should You Take?June 28, 2023 | fool.comBellus Health (NASDAQ: BLU)June 27, 2023 | msn.comThese Canadian Biotech Stocks Are Quietly Changing the Face of HealthcareJune 25, 2023 | finance.yahoo.comBLU.TO - BELLUS Health Inc.June 17, 2023 | markets.businessinsider.comBTIG Reaffirms Their Hold Rating on BELLUS Health (BLU)May 10, 2023 | ca.finance.yahoo.comTSX Stocks in the Healthcare Industry: Which Ones Are Worth Your Money?May 10, 2023 | finance.yahoo.comShould You Buy Bellus Health (BLU) After Golden Cross?May 2, 2023 | theglobeandmail.comClosing Bell: Bellus Health Inc up on Tuesday (BLU)April 26, 2023 | theglobeandmail.comBELLUS Health: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (BLU)April 26, 2023 | finance.yahoo.comBELLUS Health Announces Meeting UpdatesApril 21, 2023 | benzinga.comMoore Kuehn Encourages BLU, STSA, RXDX, STSA, and CHRA Investors to Contact Law FirmApril 19, 2023 | finance.yahoo.comBellus Health (BLU) Stock Up 99% on $2B Buyout Offer From GSKApril 19, 2023 | theglobeandmail.comGSK’s $2-billion purchase of Bellus delivers second big exit for Montreal’s Bellini familyApril 19, 2023 | reuters.comGSK bets $2 bln on Bellus cough drug to soothe pipeline fearsApril 18, 2023 | markets.businessinsider.comLifeSci Capital Reaffirms Their Hold Rating on BELLUS Health (BLU)April 18, 2023 | theglobeandmail.comGSK signs deal to buy Canadian drug developer Bellus Health for US$2 billionApril 18, 2023 | finance.yahoo.comBellus Health Soars 99% As GSK Joins Buyout Bonanza With $2 Billion DealApril 18, 2023 | cnbc.comStocks making the biggest moves midday: Southwest Airlines, Goldman Sachs, Bellus Health and moreSee More Headlines Receive BLU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BELLUS Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/10/2021Today6/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:BLU CUSIPN/A CIK1259942 Webwww.bellushealth.com Phone(450) 680-4500Fax45-0680-4501Employees74Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.72) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-76,080,000.00 Net Margins-578,586.63% Pretax Margin-578,226.56% Return on Equity-24.27% Return on Assets-23.14% Debt Debt-to-Equity RatioN/A Current Ratio33.42 Quick Ratio33.42 Sales & Book Value Annual Sales$15,000.00 Price / Sales124,613.93 Cash FlowN/A Price / Cash FlowN/A Book Value$3.09 per share Price / Book4.77Miscellaneous Outstanding Shares126,812,000Free Float96,162,000Market Cap$1.87 billion OptionableNot Optionable Beta0.19 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Roberto Francesco Bellini (Age 43)Pres, CEO & Director Comp: $790.35kMr. Ramzi Benamar (Age 50)Chief Financial Officer Comp: $650.48kDr. Andreas Orfanos FFPM (Age 64)M.B.B.Ch, MBA, Chief Operating Officer Comp: $417.58kDr. Denis Garceau Ph.D. (Age 66)Chief Scientific Officer Comp: $496.56kDr. Catherine M. Bonuccelli M.D. (Age 65)Chief Medical Officer Comp: $741.66kMr. Daniel MatthewsDirector of Investor Relations & CommunicationsMr. Tony Matzouranis (Age 50)Chief Bus. Officer Mr. Sebastien Roy (Age 47)Corp. Sec. More ExecutivesKey CompetitorsLianBioNASDAQ:LIANPHAXIAM TherapeuticsNASDAQ:PHXMPolarityTENASDAQ:PTEIQ9 Meters BiopharmaNASDAQ:NMTRHumanigenNASDAQ:HGENView All Competitors BLU Stock Analysis - Frequently Asked Questions How were BELLUS Health's earnings last quarter? BELLUS Health Inc. (NASDAQ:BLU) released its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.22) by $0.07. BELLUS Health had a negative net margin of 578,586.63% and a negative trailing twelve-month return on equity of 24.27%. What other stocks do shareholders of BELLUS Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other BELLUS Health investors own include Big Lots (BIG), Party City Holdco (PRTY), Washington Prime Group (WPG), Akorn (AKRXQ), Akers Biosciences (AKER), Akebia Therapeutics (AKBA), Adamis Pharmaceuticals (ADMP), ADMA Biologics (ADMA) and Acasti Pharma (ACST). This page (NASDAQ:BLU) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more poten...Stansberry Research | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredMy 3 Top CryptocurrenciesMore than a decade after the first Bitcoin was mined, people are finally realizing something very important......Manward Press | SponsoredAn utter travestyThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredMoonshot Coins for the Current Crypto RunAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BELLUS Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BELLUS Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.